Structure-function studies of ETS transcription factors

Critical Reviews in Oncogenesis

Volumn 11, Issue 3-4, 2000, Pages 227-253

  Mimeault, M ^a  

^a Faculté des Sciences Pharmaceutiques et Biologiques Université de Lille   (France)

Author keywords

And metastasis; DNA binding domain; ETS protein; T and B cell regulation; Transactivation and transrepression domains; Tumor growth

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2;

APOPTOSIS; CELL TRANSFORMATION; DNA BINDING; DNA SEQUENCE; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; METASTASIS; MOLECULAR INTERACTION; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; TUMOR GROWTH;

EID: 0034442010     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevoncog.v11.i34.20     Document Type: Review

References (130)

1. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage
2. Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells
3. A direct physical association between ETS and AP-1 transcription factors in normal human T cells
4. The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner
5. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer
6. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions
7. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 protooncogene
8. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma
9. A single amino-acid substitution in the Ets domain alters core DNA binding specificity of Ets1 to that of the related transcription factors Elf1 and E74
10. How tumors become angiogenic
11. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex
12. Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains
13. ESX: A structurally unique Ets overexpressed early during human breast tumorigenesis
14. PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells
15. Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate
16. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells
17. The Ets family of proteins: Weak modulators of gene expression in quest for transcriptional partners
18. Regulation of tumor cell invasion by extracellular matrix
19. Collagen-induced morphogenesis and expression of the alpha 2-intergrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells
20. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
21. Structure-function relationships of the PEA3 group of Ets-related transcription factors
22. Oncogene-initiated aberrant signalling engenders the metastatic phenotype: Synergistic transcription factor interactions are targets for cancer therapy
23. Secondary structure of the ETS domain places murine Ets-1 in the superfamily of winged helix-turn-helix DNA-binding proteins
24. Solution structure of the ETS domain from murine Ets-1: A winged helix-turn-helix DNA binding motif
25. Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene
26. The Ets1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells
27. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites
28. Oncogenic Neu/ErbB-2 increases Ets, AP-1, and NFk-B-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation
29. The ETS family of transcriptional regulators
30. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and protein-protein interactions
31. The c-ets-1 protooncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts
32. Net-b, a Ras-insensitive factor that form ternary complexes with serum response element of the fos promoter
33. Fusion of PDGF receptor β to a novel ets-1 like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
34. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
35. Oligomerization of the ABL tyrosine kinase by Ets protein TEL in human leukemia
36. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences
37. Identification of ETS domain proteins in murine T lymphocytes that interact with the moloney murine leukemia virus enhancer
38. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic TI disease
39. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential bindings of ETS family to promoter sequences of the mb-1 gene
40. Patterns and emerging mechanisms of the angiogenies switch during tumorigenesis
41. Ets-related protein E1A-F can activate three different matrix mettaloproteinase gene promoters
42. TCF
43. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation
44. Oncoprotein networks
45. An RNA-binding protein gene TLS/FUS is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation
46. Role of ets factors in the activity and endothelial cell specificity of the mouse tie gene promoter
47. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
48. Activation of ternary complex factor Elk-1 by MAP kinases
49. Gene regulation by Ets protein
50. The ETS-related transcription factor ERM is a nuclear target of signaling cascade involving MAPK and PKA
51. p300/cAMP-response element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter
52. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1
53. Characterization of the cooperative function of inhibitory sequences of Ets-1
54. A domain of TEL conserved in a subset of Ets proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein
55. Fusion of an ETS-family gene E1AF, to EWS by t(17;22) (q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy
56. A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells
57. Navet cis-acting elements in the human platelet-derived growth factor β-chain core promoter that mediate gene expression in cultured vascular endothelial cells
58. Expression of the ets-1 protooncogene correlates with malignant potential in human astrocytic tumors
59. Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors
60. A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex
61. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
62. Two functionally distinct domains responsible for transactivation by the Ets family member ERM
63. Mitogenic signaling by colony-stimulating factor-1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression
64. Transcriptional repression is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation
65. Solution structure of the ets domain of fli-1 when bound to DNA
66. The secondary structure of the ets domain of human Fli-1 resembles that of the helix-turn-helix DNA-binding motif of the Escherichia coli catabolite gene activator protein
67. DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism
68. Characterization of the human interleukin-2 receptor β-chain gene promoter: Regulation of promoter activity by ets gene products
69. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
70. ERF: Genomic organization, chromosomal localization and promoter analysis of the human and mouse genes
71. Tel is a sequence-specific transcriptional repressor
72. Transcription factors of the Ets family and morphogenesis of the vascular tree
73. Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis
74. The Ewing's sarcoma EWS/FLI-1 gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1
75. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1
76. Ets-1 and Ets-2 protooncogenes exhibit differential and restricted expression patterns during Xenopus laevis oogenesis and embryogenesis
77. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties
78. Molecular characterization of the ets-related human transcription factor ER81
79. A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression
80. Defective activation and survival of T cells lacking the Ets-1 transcription factor
81. Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors
82. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 heptoma cells
83. Interaction of murine Ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif
84. Ets-1 converts endothelial cells to the angiogenic phetotype by inducing the expression of matrix metalloproteinases and integrin beta3
85. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family
86. The activity of the ets Transcription factor PEA3 is regulated by two distinct MAPK cascades
87. Tumoral vascularization: Physiopathology and therapeutic prospects
88. The novel activation of ABL by fusion to an ets-related gene, TEL
89. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth
90. Expression of c-ets-1 in early embryo mesoderm-relationship to the hemangioblastic lineage
91. A new member of the ETS family fused to EWS in Ewing tumors
92. Modulation of trannscription factor Ets-1 DNA binding: DNA-induced unfolding of an α helix
93. Transcriptional activation by recruitment
94. Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity
95. Vasculogenesis
96. Regulation of E-cadherin gene expression during tumor progression: The role of a new Ets-binding site and the E-pal element
97. Expression of ets family genes in hematopoietic cells
98. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester
99. Characterization of the human CD4 gene promoter: Transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins
100. The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family
101. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
102. The ets gene family
103. The Ets-2 transcription factor enhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism
104. ERF: An ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation
105. Role of VEGF-FLT receptor system in normal and tumor angiogenesis
106. Characterization of the Elk-1 ETS DNA-binding domain
107. A second Ewings sarcoma translocation, t(2122), fuses the Ews gene to another ETS family transcription factor, ERG
108. T-cell development in PU.I-deficient mice
109. Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion?
110. Analyse moléculaire de l'angiogénèse tumorale
111. Expression of the transcription factor c-Ets-1 correlates with the occurrence of invasive processes during normal and pathological development
112. ETS1 and ETS2 in p53 regulation: Spatial separation of ETS binding sites (EBS) modulate protein DNA interaction
113. A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene
114. Evolutionary conserved ets family members display distinct DNA binding specificities
115. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL
116. The Ets family of transcription factors
117. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway
118. Reversion of Ras transformed cells by Ets transdominant mutants
119. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor
120. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements
121. Correction of the NMR structure of the ETS1/DNA complex
122. c-ets-1 protooncogene is a transcription factor expressed in endothelial cells during tumor vascularisation and other forms of angiogenesis in humans
123. Stromal expression of ets1 transcription factor correlates with tumor invasion
124. Inhibition of angiogenesis in vivo by ets-1 antisense oligonucleotides-inhibition of Ets-1 transcription factor expression by the antibiotic fumagillin
125. Defective trophoblast function in mice with a targeted mutation of Ets-2
126. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-ETS-1 and c-ETS-2
127. A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions
128. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with Ets-1 in endothelial cells
129. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias
130. Combinatorial generation of variable fusion proteins in the Ewing family of tumours